Shuttle Pharmaceuticals Files 8-K on Financials
Ticker: SHPH · Form: 8-K · Filed: Mar 22, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Mar 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
Shuttle Pharma dropped an 8-K on financials - check it for the latest.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on March 22, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates that Shuttle Pharmaceuticals is providing updates on its financial status and operational results to the SEC, which is important for investors to monitor the company's performance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not contain any immediately alarming or significant new risks.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- March 22, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
FAQ
What specific financial results are being reported in this 8-K?
The provided text of the 8-K filing does not contain specific financial results or figures.
What is the primary purpose of this 8-K filing for Shuttle Pharmaceuticals?
The primary purpose is to report on the company's results of operations and financial condition, and to file financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 22, 2024.
Where are Shuttle Pharmaceuticals' principal executive offices located?
Shuttle Pharmaceuticals' principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the Standard Industrial Classification (SIC) code for Shuttle Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Shuttle Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 528 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-03-22 09:00:35
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 21KB
- 0001493152-24-010919.txt ( ) — 238KB
- shph-20240322.xsd (EX-101.SCH) — 3KB
- shph-20240322_lab.xml (EX-101.LAB) — 33KB
- shph-20240322_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: March 22, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer